A multicenter clinical study in Austria has shown that a new, highly precise ultrasound approach can successfully target and ...

Several new clinical trials in prostate cancer have started recruiting in recent months. Maybe one of your patients could benefit from enrolling? Metastatic castration-sensitive prostate cancer.

A 68-year-old man presented to the emergency department with haematuria and penile pain. His medical history included benign prostatic hyperplasia, but no follow-up examinations had been performed.

As the prostate cancer treatment landscape continues to evolve, understanding the risks and benefits of each approach is critical for patients. Prostate cancer treatment continues to evolve, and ...

The PROSTATE-IQ trial uses the ArteraAI Prostate Test to personalize treatment for prostate cancer recurrence post-prostatectomy, potentially reducing hormone therapy use. The trial stratifies ...

A multicenter study led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute of St. Joseph's Health Care London (Lawson), and University Health Network (UHN) has ...

Early detection of prostate cancer can be life-saving — but determining whether the disease is localized or has spread requires a precise, multi-step evaluation. Here, Dr. Neha Maithel, medical ...

BALTIMORE, Nov. 13, 2025 (GLOBAL NEWSWIRE) — The Urology Care Foundation (UCF), the official foundation of the American Urological Association (AUA), and the Prostate Cancer Foundation (PCF) today ...

The Interaktor app was well-received by patients undergoing radiotherapy for prostate cancer seeking to monitor and manage their symptoms.The effectiveness of the Interaktor app was evaluated in a ...

GRAND RAPIDS, Mich. (WOOD) — Like many patients, a diagnosis for prostate cancer came out of nowhere for Grand Rapids resident Larry Vaughn. “It was scary at the time,” Vaughn said. “No symptoms. I ...